Format
Sort by
Items per page

Send to

Choose Destination

Best matches for drd4 schizophrenia:

Search results

Items: 1 to 20 of 217

1.

A meta-analysis of data associating DRD4 gene polymorphisms with schizophrenia.

Xu FL, Wu X, Zhang JJ, Wang BJ, Yao J.

Neuropsychiatr Dis Treat. 2018 Jan 3;14:153-164. doi: 10.2147/NDT.S156479. eCollection 2018.

2.

Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines.

Taraskina AE, Nasyrova RF, Zabotina AM, Sosin DN, Sosina КА, Ershov EE, Grunina MN, Krupitsky EM.

BMC Psychiatry. 2017 Dec 8;17(1):394. doi: 10.1186/s12888-017-1562-1.

3.

Gene-gene interaction between DRD4 and COMT modulates clinical response to clozapine in treatment-resistant schizophrenia.

Rajagopal VM, Rajkumar AP, Jacob KS, Jacob M.

Pharmacogenet Genomics. 2018 Jan;28(1):31-35. doi: 10.1097/FPC.0000000000000314.

PMID:
29087970
4.

Gene-environment interaction and psychiatric disorders: Review and future directions.

Assary E, Vincent JP, Keers R, Pluess M.

Semin Cell Dev Biol. 2018 May;77:133-143. doi: 10.1016/j.semcdb.2017.10.016. Epub 2017 Oct 18. Review.

PMID:
29051054
5.

cAMP levels in lymphocytes and CD4+ regulatory T-cell functions are affected by dopamine receptor gene polymorphisms.

Cosentino M, Kustrimovic N, Ferrari M, Rasini E, Marino F.

Immunology. 2018 Mar;153(3):337-341. doi: 10.1111/imm.12843. Epub 2017 Oct 16.

PMID:
28940477
6.

The effects of buspirone on occupancy of dopamine receptors and the rat gambling task.

Di Ciano P, Cormick PM, Stefan C, Wong E, Kim A, Remington G, Le Foll B.

Psychopharmacology (Berl). 2017 Nov;234(22):3309-3320. doi: 10.1007/s00213-017-4715-5. Epub 2017 Aug 19.

PMID:
28825117
7.

A computational network analysis based on targets of antipsychotic agents.

Gao L, Feng S, Liu ZY, Wang JQ, Qi KK, Wang K.

Schizophr Res. 2018 Mar;193:154-160. doi: 10.1016/j.schres.2017.07.041. Epub 2017 Jul 26.

PMID:
28755876
8.

[A role of interactions between N-methyl-D-aspartate and dopamine receptors in facial emotion recognition impairment in schizophrenia].

Alfimova MV, Golimbet VE, Korovaitseva GI, Lezheiko TV, Tikhonov DV, Ganisheva TK, Berezin NB, Snegireva AA, Shemiakina TK.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(6):47-52. doi: 10.17116/jnevro20171176147-52. Russian.

PMID:
28745671
9.

Hemoglobins emerging roles in mental disorders. Metabolical, genetical and immunological aspects.

Altinoz MA, Ince B.

Int J Dev Neurosci. 2017 Oct;61:73-85. doi: 10.1016/j.ijdevneu.2017.06.007. Epub 2017 Jul 8. Review.

PMID:
28694195
10.

Chemistry-based molecular signature underlying the atypia of clozapine.

Cardozo T, Shmelkov E, Felsovalyi K, Swetnam J, Butler T, Malaspina D, Shmelkov SV.

Transl Psychiatry. 2017 Feb 21;7(2):e1036. doi: 10.1038/tp.2017.6.

11.

Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia.

Eisenstein SA, Bogdan R, Chen L, Moerlein SM, Black KJ, Perlmutter JS, Hershey T, Barch DM.

J Psychiatr Res. 2017 Mar;86:9-17. doi: 10.1016/j.jpsychires.2016.11.007. Epub 2016 Nov 17.

12.

Uncovering obsessive-compulsive disorder risk genes in a pediatric cohort by high-resolution analysis of copy number variation.

Gazzellone MJ, Zarrei M, Burton CL, Walker S, Uddin M, Shaheen SM, Coste J, Rajendram R, Schachter RJ, Colasanto M, Hanna GL, Rosenberg DR, Soreni N, Fitzgerald KD, Marshall CR, Buchanan JA, Merico D, Arnold PD, Scherer SW.

J Neurodev Disord. 2016 Oct 18;8:36. doi: 10.1186/s11689-016-9170-9. eCollection 2016.

13.

Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients.

Ferrari M, Comi C, Marino F, Magistrelli L, De Marchi F, Cantello R, Riboldazzi G, Bono G, Cosentino M.

Eur J Clin Pharmacol. 2016 Nov;72(11):1335-1341. Epub 2016 Aug 6.

PMID:
27497990
14.

Associations between a locus downstream DRD1 gene and cerebrospinal fluid dopamine metabolite concentrations in psychosis.

Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG.

Neurosci Lett. 2016 Apr 21;619:126-30. doi: 10.1016/j.neulet.2016.03.005. Epub 2016 Mar 5.

15.

[Brain neurotransmitter systems gene Polymorphism: the Search for pharmacogenetic markers of efficacy of haloperidol in Russians and Tatars].

Gareeva AE, Kinyasheva KO, Galaktionova DY, Sabirov ET, Valinourov RG, Chudinov AV, Zasedatelev AS, Nasedkina TV, Khusnutdinova EK.

Mol Biol (Mosk). 2015 Nov-Dec;49(6):959-67. doi: 10.7868/S0026898415050079. Russian.

16.

Pharmacogenetics and antipsychotic treatment response.

Naumovska Z, Nestorovska AK, Filipce A, Sterjev Z, Brezovska K, Dimovski A, Suturkova LJ.

Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2015;36(1):53-67. Review.

PMID:
26076775
17.

Association of GRIN1, ABCB1, and DRD4 genes and response to antipsychotic drug treatment in schizophrenia.

Pai P, Arathil P, Kotambail A, Nair R, Gupta M, Moily NS, Kukreti R, Jain S, Rai PS, Gopinath PM, Sharma PS, Satyamoorthy K.

Psychiatr Genet. 2015 Jun;25(3):135-6. doi: 10.1097/YPG.0000000000000079. No abstract available.

PMID:
25714447
18.

Genetic association between the DRD4 promoter polymorphism and clozapine-induced sialorrhea.

Rajagopal V, Sundaresan L, Rajkumar AP, Chittybabu C, Kuruvilla A, Srivastava A, Balasubramanian P, Jacob KS, Jacob M.

Psychiatr Genet. 2014 Dec;24(6):273-6. doi: 10.1097/YPG.0000000000000058.

PMID:
25304228
19.

Specific and common genes implicated across major mental disorders: a review of meta-analysis studies.

Gatt JM, Burton KL, Williams LM, Schofield PR.

J Psychiatr Res. 2015 Jan;60:1-13. doi: 10.1016/j.jpsychires.2014.09.014. Epub 2014 Sep 28. Review.

PMID:
25287955
20.

Dissociable genetic contributions to error processing: a multimodal neuroimaging study.

Agam Y, Vangel M, Roffman JL, Gallagher PJ, Chaponis J, Haddad S, Goff DC, Greenberg JL, Wilhelm S, Smoller JW, Manoach DS.

PLoS One. 2014 Jul 10;9(7):e101784. doi: 10.1371/journal.pone.0101784. eCollection 2014.

Supplemental Content

Loading ...
Support Center